Skip to main content
. 2020 Apr 29;10:7238. doi: 10.1038/s41598-020-64380-y

Figure 4.

Figure 4

Immunohistochemistry for NGAL and KIM-1 in the kidney. Representative images of immunohistochemistry for NGAL (a) and KIM-1 (c) in kidney sections from LETO, OLETF, and OLETF treated with empagliflozin (Empa) that were sampled after a sham operation (Sham) or myocardial infarction (MI). Summary data of NGAL- (b) and KIM-1- (d) positive areas. N = 6. *P < 0.05.